Clinical Trials Using CAR-T Cells Are Extremely Promising

Fact Checked

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles. Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated March 31st, 2021

Clinical Trials Using CAR-T Cells Are Extremely Promising

NOW
PLAYING
CAR T-Cell Therapy: A Step-By-Step Guide to Having This Breakthrough Treatment
NOW
PLAYING
The Promise of CAR T-Cell Therapy for Multiple Myeloma
NOW
PLAYING
Cancer Innovation: DNA-Altering CRISPR Used to Target Cancer For First Time in U.S. Trial
NOW
PLAYING
How is CAR-T Therapy Used to Treat Multiple Myeloma?
NOW
PLAYING
Does CAR-T Therapy Work for Relapse?
NOW
PLAYING
CAR-T Therapy for Multiple Myeloma
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.